Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Neuralstem: Investigators are Very Positive on NSI-566 Results in ALS (CUR, Buy, $3.27)

Investment Perspective

The key investigators for the treatment of ALS with Neuralstem’s NSI-566 neural stem cells have been extremely positive in…
Read more…